Zobrazeno 1 - 10
of 502
pro vyhledávání: '"W, Woloszczuk"'
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 95:275-278
Serum levels of osteocalcin (OC), a 49 amino acid bone matrix protein, have been found to be a biochemical parameter of bone formation. In order to study bone metabolism in aging subjects we measured serum levels of OC, parathyroid hormone (PTH) and
Autor:
B. Niederle, R. Roka, W. Woloszczuk, G. Schernthaner, Edith Schubert, E. Borek, A. Karner, Eva Hirsch, F. Seidl, F. Pesendorfer, Theresia Matzinger, G. Lindtner, R. Kaiser
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 113:163-168
Serum calcium determination of 11,588 hospitalized patients during a twelve-month period revealed hypercalcaemia in 74 (0.64%). Further clinical and biochemical investigation established primary hyperparathyroidism in 20 of them (27%), and in 15 (20%
Autor:
G. Geyer, Josef S. Smolen, L Erlacher, H. Ekhart, Wolfgang Graninger, W. Woloszczuk, C. Fialka, K Bobacz, R. Maier
Publikováno v:
Osteoarthritis and Cartilage. 11:665-672
Objective: Since the development of posttraumatic osteoarthritis (OA) is a relatively slow process, estimation of OA risk would be of value with regard to chondroprotective measures and medication. In this study we investigated the significance of pr
Autor:
W. Woloszczuk
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 57:95-99
In 1995 a proposal to establish a Committee on Bone Markers was presented to the Scientific Division of the International Federation of Clinical Chemistry. Following the Terms of Reference that were adopted by the Committee two tasks were selected as
Autor:
W. Woloszczuk, A. Trubrich, Heinrich Resch, Roland Kocijan, Christian Muschitz, Judith Haschka, S. Dinu, C. Bittighofer, Janina M. Patsch, S. Kapiotis
Publikováno v:
Bone. 51:S19-S20
Trabecular Bone Score (TBS) is a novel grey-scale textural analysis to estimate microarchitecture from the Spine DXA. TBS correlates well with more direct measures of bone microarchitecture independent of BMD. The aim of the study was to compare gend
Autor:
S, Piemonte, E, Romagnoli, C, Bratengeier, W, Woloszczuk, A, Tancredi, J, Pepe, C, Cipriani, S, Minisola
Publikováno v:
Journal of endocrinological investigation. 35(9)
This study was carried out in order to evaluate the effect of 18-month treatment with PTH (1-34) or PTH (1-84) on serum sclerostin levels in humans.We investigated 10 women with severe osteoporosis, previously treated with alendronate and 20 untreate
Autor:
Stergios A. Polyzos, C. Bratengeier, Athanasios D. Anastasilakis, Athanasios Papatheodorou, Evangelos Terpos, W. Woloszczuk
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 23(3)
Sclerostin is expressed by osteocytes and inhibits bone formation by osteoblasts. In this study, serum sclerostin was positively correlated with either lumbar spinal bone mineral density or T-score. Furthermore, serum sclerostin was increased after 6
Publikováno v:
Bone and Mineral. 8:103-108
Serum levels of osteocalcin (OC) have been found to be a specific biochemical parameter of bone formation. We measured serum levels of osteocalcin, parathyroid hormone (PTH) and 25-hydroxyvitamin D (25(OH)D) in 49 patients with liver cirrhosis, who a
Autor:
Sophie, Ziegler, A, Niessner, J, Slany, M M, Müller, Angelika, Heinschink, Elke, Billensteiner, W, Woloszczuk, Und G, Geyer
Publikováno v:
Acta medica Austriaca. 30(2)
In 19 marathon runners of both sexes, plasma concentrations of total creatine kinase (CK) activity, CKMB mass, myoglobin and troponin I were determined before and immediately after the race. Total CK activity and myoglobin increased significantly in